isomethyleugenol has been researched along with Local Neoplasm Recurrence in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.13) | 18.2507 |
2000's | 6 (12.77) | 29.6817 |
2010's | 22 (46.81) | 24.3611 |
2020's | 18 (38.30) | 2.80 |
Authors | Studies |
---|---|
Fujii, T; Ichimura, K; Kawauchi, D; Kobayashi, T; Kondo, A; Nakano, T; Narita, Y; Sasaki, N; Satomi, K; Takahashi, M; Tomiyama, A; Uchida, E; Wada, K; Yamamuro, S; Yoshino, A | 1 |
Baccarani, U; Bertozzi, S; Bulfoni, M; Cedolini, C; Cesselli, D; Corradetti, B; Londero, AP; Mariuzzi, L; Marzinotto, S; Orsaria, M; Viola, L | 1 |
Balducci, PM; Cagnani, R; Cari, L; Cochetti, G; Del Zingaro, M; Maulà, V; Mearini, E; Nocentini, G; Paladini, A; Rossi de Vermandois, JA; Suvieri, C | 1 |
Apanovich, NV; Braga, EA; Brovkina, OI; Burdennyy, AM; Dmitriev, AA; Filippova, EA; Fridman, MV; Karpukhin, AV; Kazubskaya, TP; Kushlinskii, NE; Loginov, VI; Lukina, SS; Pronina, IV; Stilidi, IS; Uroshlev, LA | 1 |
Baudre, L; Baulande, S; Bento, ST; Bohec, M; Dahmani, A; Durand, A; Eisele, A; Foulon, S; Grosselin, K; Landragin, C; Letouzé, E; Lyne, AM; Marangoni, E; Marsolier, J; Perié, L; Prompsy, P; Salomon, AV; Sourd, L; Trouchet, A; Vallot, C | 1 |
He, JL; Liang, JJ; Luo, XJ; Tang, XK; Wan, Y; Wang, SB; Zeng, D; Zhang, L; Zhao, YY; Zhu, XJ | 1 |
Cao, X; Ding, Z; Fan, Z; Guo, H; He, Z; Jiang, C; Jiang, W; Jin, W; Ju, L; Leng, Y; Li, L; Li, S; Liu, D; Lu, S; Peng, M; Qian, G; Qian, K; Wang, G; Wang, X; Weng, H; Wu, K; Xiao, Y; Xie, X; Zhang, Y; Zhao, J | 1 |
Ali, AM; Salih, GF | 1 |
Gan, Y; Hou, W; Li, C; Peng, D; Wang, B; Wang, L; Xiong, W; Yuan, P; Zhou, L | 1 |
Cai, G; Cai, S; Dai, W; Han, L; Liu, R; Luo, W; Mo, S; Wang, D; Wang, H; Wang, R; Wang, Y; Wang, Z; Xu, Y; Ye, L; Zhou, S | 1 |
Chen, Y; Fang, H; Guo, Y; Huang, C; Jia, C; Li, T; Liu, A; Lu, C; Lv, Y; Mo, K; Mou, Y; Song, K; Song, Q; Song, X; Song, Y; Sun, P; Sun, Q; Tian, R; Wang, K; Wei, S; Yang, D; Yu, G; Yu, X; Yu, Y; Zhang, H; Zhou, J | 1 |
Amorim, M; Antunes, L; de Sousa, SP; Fontes-Sousa, M; Henrique, R; Jerónimo, C; Lobo, J; Lobo, S; Lopes, P; Salta, S | 1 |
Chen, WJ; Han, H; He, XS; Kang, EM; Liu, WP; Lv, JN; Wang, GH; Wang, J; Yu, YB; Zhang, W; Zhang, X; Zhang, YL | 1 |
Chen, X; Dong, Z; Han, W; Hu, S; Jiang, X; Li, W; Liao, B; Liu, Y; Shen, J; Wang, Z; Xiao, M; Ye, J | 1 |
Emami Razavi, A; Jahangiri, R; Jamialahmadi, K; Mosaffa, F; Teimoori-Toolabi, L | 1 |
Hara, A; Inoue, F; Kukita, A; Osuga, Y; Sone, K; Taguchi, A; Takahashi, Y; Tanikawa, M; Toyohara, Y; Tsuruga, T | 1 |
Godinez-Victoria, M; Hernandez-Caballero, ME; Seseña-Mendez, E; Sierra-Ramirez, JA | 1 |
Cao, X; Guo, C; Li, Y; Yan, Y; Zhang, F; Zhang, J | 1 |
Brodak, M; Chmelarova, M; Husek, P; Pacovsky, J; Podhola, M | 1 |
Li, B; Qiu, J; Yuan, Y | 1 |
Fukayama, M; Hiraoka, N; Kawai, A; Komiyama, M; Makise, N; Nakatani, F; Yonemori, K; Yoshida, A | 1 |
Alvarado, Y; Boddu, P; Borthakur, G; Bose, P; Brandt, M; Cortes, J; Daver, N; DiNardo, CD; Garcia-Manero, G; Jabbour, EJ; Jorgensen, J; Kadia, T; Kantarjian, H; Konopleva, M; Naqvi, K; Pemmaraju, N; Pierce, S; Ravandi, F; Yilmaz, M | 1 |
Bähr, O; Belka, C; Braun, C; Gerlach, R; Glas, M; Goldbrunner, R; Hänel, M; Hattingen, E; Hau, P; Herrlinger, U; Junold, N; Kebir, S; Kortmann, RD; Krex, D; Mack, F; Niessen, M; Proescholdt, M; Rohde, V; Sabel, M; Schäfer, N; Schaub, C; Schlegel, U; Schmidt-Graf, F; Steinbach, JP; Stuplich, M; Tzaridis, T; Vatter, H; Weyerbrock, A | 1 |
Choi, SH; Chun, SJ; Kim, IH; Kim, JW; Kim, TM; Lee, ST; Park, CK; Park, SH | 1 |
Abril, L; Archila, P; Arrieta, O; Balaña, C; Behaine, J; Bermúdez, S; Cardona, AF; Carranza, H; Cifuentes, H; Feo, O; González, D; Hakim, F; Jacobo, J; Jiménez, E; Mantilla, MI; Marquez, JC; Mejía, JA; Ortiz, LD; Otero, J; Penagos, P; Pineda, D; Pino, LE; Ramón, JF; Ricaurte, L; Rodríguez, J; Rojas, L; Rosell, R; Ruiz-Patiño, A; Useche, N; Vargas, C; Wills, B; Zatarain-Barrón, ZL | 1 |
Cantero, D; de Velasco, G; Hernández-Laín, A; Hilario, A; Manneh Kopp, RA; Pérez Núñez, A; Ramos, A; Ruano, Y; Sánchez-Gómez, P; Sepúlveda-Sánchez, JM; Toldos, O | 1 |
Bavafaye-Haghighi, E; Besenbacher, S; Borre, M; Hoyer, S; Kristensen, H; Mouritzen, P; Orntoft, TF; Rasmussen, AK; Sorensen, KD; Strand, SH | 1 |
Bachmann, A; Baumann, C; Behbahani, TE; Ellinger, J; Göke, F; Heukamp, LC; Müller, SC; Rogenhofer, S | 1 |
Benard, A; de Graaf, W; Goossens-Beumer, IJ; Horati, H; Kuppen, PJ; Putter, H; van de Velde, CJ; van Hoesel, AQ; Zeestraten, EC | 1 |
Deng, J; Guo, W; He, Y; Hu, J; Liao, Y; Liu, J; Liu, S; Song, H; Sun, B; Wang, X; Wang, Y; Wu, Y; Xu, D; Ye, D; Yin, H; Yu, W; Zhang, L; Zhang, Z; Zhong, S; Zhou, BP | 1 |
Guerrero-Preston, R; Hayashi, M; Koch, WM; Sidransky, D | 1 |
Fan, YC; Gao, S; Ji, XF; Jia, YB; Li, F; Li, XY; Liu, C; Sun, FK; Sun, Q; Wang, K; Wang, LY; Zhao, J | 1 |
Deng, QK; Fu, XL; Li, WP; Lin, YL; Ma, JG; Wang, YH | 1 |
Harris, CC; Robles, AI | 1 |
Castellano, D; Costa, C; de la Rosa, F; Duarte, J; Dueñas, M; Fernández-Grajera, M; López-Calderón, FF; Martínez-Fernández, M; Muñoz, HG; Paramio, JM; Rubio, C; Saiz-Ladera, C; Segovia, C; Villacampa, F | 1 |
Addeo, R; Caraglia, M; De Santi, MS; Del Prete, S | 1 |
Bangma, CH; Beukers, W; Eijkemans, MJ; Lingsma, HF; Munoz, JR; Schouten, JP; van der Keur, KA; Zuiverloon, TC; Zwarthoff, EC | 1 |
Bhagat, G; Chadburn, A; Chan, J; Chiarenza, A; Dalla-Favera, R; Elliot, O; Fabbri, G; Gaidano, G; Grunn, A; Ma, J; Messina, M; Mullighan, CG; Pasqualucci, L; Rabadan, R; Rossi, D; Trifonov, V; Wells, VA | 1 |
Bastian, PJ; Ellinger, J; Gütgemann, I; Heukamp, LC; Hofstädter, F; Kahl, P; Müller, SC; Rogenhofer, S; von der Gathen, J; von Ruecker, A; Walter, B | 1 |
Jang, SJ; Kim, DK; Kim, YS; Park, SI; Song, JS | 1 |
Bosse, T; Creutzberg, CL; Jobsen, JJ; Jürgenliemk-Schulz, IM; Lutgens, LC; Nout, RA; Smit, VT; Ter Haar, NT; van der Steen-Banasik, EM; van Eijk, R | 1 |
Kitamura, T; Tomita, K | 1 |
Marte, B | 1 |
Grunstein, M; Horvath, S; Kurdistani, SK; Seligson, DB; Shi, T; Tze, S; Yu, H | 1 |
Fujiwara, H; Hagiwara, A; Ichikawa, D; Ikoma, D; Ikoma, H; Kikuchi, S; Ochiai, T; Okamoto, K; Otsuji, E; Sai, S; Tani, N; Tomita, H; Ueda, Y; Yamagishi, H | 1 |
Fukushima, T; Katayama, Y; Komine, C; Ogino, A; Ohta, T; Watanabe, T; Yachi, K; Yoshino, A | 1 |
Cordon-Cardo, C; Fradet, Y; Lacombe, L; LaRue, H; Meyer, F; Moore, L; Orlow, I; Osman, I; Rabbani, F | 1 |
2 review(s) available for isomethyleugenol and Local Neoplasm Recurrence
Article | Year |
---|---|
Targeting Epigenetic Regulators for Endometrial Cancer Therapy: Its Molecular Biology and Potential Clinical Applications.
Topics: Acetylation; Chromatin Immunoprecipitation Sequencing; Disease Progression; DNA Methylation; Endometrial Neoplasms; Epigenesis, Genetic; Female; Gene Expression Regulation; Histones; Humans; Methylation; Neoplasm Recurrence, Local; RNA, Untranslated | 2021 |
[The mechanism and predictive factors of hormone-independent recurrence of prostate cancer].
Topics: Androgens; Apoptosis; Cadherins; Caveolin 1; Caveolins; Cell Adhesion; Growth Substances; Humans; Male; Methylation; Mutation; Neoplasm Recurrence, Local; Promoter Regions, Genetic; Prostatic Neoplasms; Receptors, Androgen; Trinucleotide Repeats | 2002 |
2 trial(s) available for isomethyleugenol and Local Neoplasm Recurrence
Article | Year |
---|---|
Diagnostic performance of the Bladder EpiCheck methylation test and photodynamic diagnosis-guided cystoscopy in the surveillance of high-risk non-muscle invasive bladder cancer: A single centre, prospective, blinded clinical trial.
Topics: Cohort Studies; Cystoscopy; Female; Humans; Male; Methylation; Neoplasm Recurrence, Local; Prospective Studies; Urinary Bladder; Urinary Bladder Neoplasms | 2022 |
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Cell Growth Processes; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioblastoma; Humans; Irinotecan; Magnetic Resonance Imaging; Male; Methylation; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Radiotherapy; Temozolomide; Tumor Suppressor Proteins | 2018 |
43 other study(ies) available for isomethyleugenol and Local Neoplasm Recurrence
Article | Year |
---|---|
Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Female; Glioblastoma; Histones; Humans; Injections, Intraperitoneal; Lomustine; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Recurrence, Local; Nimustine; Salvage Therapy; Temozolomide; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2021 |
TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study.
Topics: Aged; Aged, 80 and over; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Beclin-1; Breast Neoplasms; Case-Control Studies; Chemotherapy, Adjuvant; Drug Resistance, Neoplasm; Female; Homeobox Protein PITX2; Homeodomain Proteins; Humans; Immunohistochemistry; Methylation; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Prognosis; Protein-Arginine N-Methyltransferases; Receptor, ErbB-2; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Sirtuin 1; Time Factors; Tissue Array Analysis; Transcription Factors | 2021 |
Aberrant Methylation of 20 miRNA Genes Specifically Involved in Various Steps of Ovarian Carcinoma Spread: From Primary Tumors to Peritoneal Macroscopic Metastases.
Topics: Carcinoma; Carcinoma, Ovarian Epithelial; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Machine Learning; Methylation; MicroRNAs; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Peritoneum; Prognosis; Recurrence; Transcriptome | 2022 |
H3K27me3 conditions chemotolerance in triple-negative breast cancer.
Topics: Drug Resistance, Neoplasm; Histones; Humans; Lysine; Methylation; Neoplasm Recurrence, Local; Triple Negative Breast Neoplasms | 2022 |
Septin 9 methylation analysis of lymph node micrometastases for predicting relapse of colorectal cancer.
Topics: Colorectal Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Methylation; Neoplasm Micrometastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Septins | 2022 |
Ultrasensitive tumour-agnostic non-invasive detection of colorectal cancer recurrence using ctDNA methylation.
Topics: Circulating Tumor DNA; Colorectal Neoplasms; Humans; Methylation; Neoplasm Recurrence, Local | 2022 |
Identification of three novel DNMT3A mutations with compromising methylation capacity in human acute myeloid leukaemia.
Topics: DNA Methylation; DNA Methyltransferase 3A; DNA Modification Methylases; Humans; Leukemia, Myeloid, Acute; Methylation; Middle Aged; Mutation; Neoplasm Recurrence, Local | 2022 |
The m
Topics: Adenocarcinoma; Clinical Relevance; Humans; Male; Methylation; MicroRNAs; Neoplasm Recurrence, Local; Prostate; Prostatic Neoplasms; RNA, Long Noncoding | 2023 |
Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation.
Topics: Biomarkers, Tumor; Circulating Tumor DNA; Cohort Studies; Colorectal Neoplasms; Female; Humans; Liquid Biopsy; Longitudinal Studies; Male; Methylation; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Risk Assessment | 2023 |
m
Topics: Adenocarcinoma of Lung; Ecosystem; Endothelial Cells; Humans; Lung Neoplasms; Methylation; Neoplasm Recurrence, Local; Phosphatidylinositol 3-Kinases; RNA-Binding Proteins; Tumor Microenvironment | 2023 |
Digital imaging-assisted quantification of H3K27me3 immunoexpression in luminal A/B-like, HER2-negative, invasive breast cancer predicts patient survival and risk of recurrence.
Topics: Biomarkers, Tumor; Breast Neoplasms; Disease-Free Survival; Down-Regulation; Female; Histones; Humans; Image Interpretation, Computer-Assisted; Kaplan-Meier Estimate; Methylation; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Precision Medicine; Prognosis; Software | 2020 |
The different role of YKL-40 in glioblastoma is a function of MGMT promoter methylation status.
Topics: Adult; Brain Neoplasms; Chitinase-3-Like Protein 1; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Epigenesis, Genetic; Female; Glioblastoma; Humans; Male; Methylation; Middle Aged; Neoplasm Recurrence, Local; Promoter Regions, Genetic; Temozolomide; Tumor Suppressor Proteins | 2020 |
YTHDF1-enhanced iron metabolism depends on TFRC m
Topics: Adenosine; Animals; Antigens, CD; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cohort Studies; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Gene Expression Regulation, Neoplastic; Humans; Hypopharyngeal Neoplasms; Hypopharynx; Iron; Male; Methylation; Mice; Neoplasm Recurrence, Local; Receptors, Transferrin; RNA-Binding Proteins; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays | 2020 |
Topics: Breast Neoplasms; DNA Methylation; Drug Resistance, Neoplasm; Female; Humans; Methylation; Neoplasm Recurrence, Local; Nuclear Receptor Coactivator 3; PAX2 Transcription Factor; Promoter Regions, Genetic; Tamoxifen | 2022 |
An insight into the promoter methylation of PHF20L1 and the gene association with metastasis in breast cancer.
Topics: Breast Neoplasms; Chromosomal Proteins, Non-Histone; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Methylation; MicroRNAs; Neoplasm Recurrence, Local; Promoter Regions, Genetic | 2021 |
Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.
Topics: Adenosine; Aged; Animals; Antigens, Neoplasm; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease-Free Survival; Female; Follow-Up Studies; Gastrectomy; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Male; Methylation; Methyltransferases; Mice; MicroRNAs; Middle Aged; Neoplasm Recurrence, Local; Polycomb Repressive Complex 2; Prognosis; Protein Biosynthesis; Stomach; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2021 |
Methylation status as a predictor of intravesical Bacillus Calmette-Guérin (BCG) immunotherapy response of high grade non-muscle invasive bladder tumor.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; BCG Vaccine; Female; Genes, Tumor Suppressor; Humans; Immunotherapy; Male; Methylation; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms | 2017 |
Reply to A. Braillon.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Methylation; Neoplasm Recurrence, Local; Smoking | 2017 |
Dedifferentiated Liposarcoma With Epithelioid/Epithelial Features.
Topics: Aged; Biomarkers, Tumor; Biopsy; Cell Dedifferentiation; Claudin-4; Diagnosis, Differential; Disease Progression; Epithelial Cells; Epithelioid Cells; Female; Gene Amplification; Histones; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Keratins; Liposarcoma; Male; Methylation; Middle Aged; Mucin-1; Neoplasm Recurrence, Local; Predictive Value of Tests; Proto-Oncogene Proteins c-mdm2; Time Factors; Treatment Outcome | 2017 |
Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Leukemia, Myeloid, Acute; Male; Methylation; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Recurrence; Risk | 2018 |
Survival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groups.
Topics: Adult; Aged; Brain Neoplasms; Combined Modality Therapy; Disease-Free Survival; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioma; Humans; Male; Methylation; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Promoter Regions, Genetic; Radiotherapy, Adjuvant; Reoperation; Retreatment; Retrospective Studies; Risk Factors; Tumor Suppressor Proteins | 2018 |
A comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastoma.
Topics: AC133 Antigen; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Bevacizumab; Brain Neoplasms; Carmustine; Chitinase-3-Like Protein 1; Colombia; DNA Modification Methylases; DNA Repair Enzymes; Drug Administration Schedule; Female; Genes, erbB-1; Genes, p53; Glioblastoma; Humans; Isocitrate Dehydrogenase; Male; Methylation; Middle Aged; Mutation; Neoplasm Recurrence, Local; Progression-Free Survival; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Survival Analysis; Tumor Suppressor Proteins; Young Adult | 2019 |
Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Immunological; Bevacizumab; Biomarkers, Tumor; Brain Neoplasms; Cerebrovascular Circulation; DNA Modification Methylases; DNA Repair Enzymes; Female; Gene Amplification; Genes, erbB-1; Glioblastoma; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Methylation; Microvessels; Middle Aged; Mitotic Index; Neoplasm Recurrence, Local; Retrospective Studies; Tissue Array Analysis; Tumor Suppressor Proteins | 2019 |
A novel combined miRNA and methylation marker panel (miMe) for prediction of prostate cancer outcome after radical prostatectomy.
Topics: Adult; Aged; Biomarkers, Tumor; Cohort Studies; Disease Progression; Humans; Kaplan-Meier Estimate; Male; Methylation; MicroRNAs; Middle Aged; Neoplasm Recurrence, Local; Nomograms; Prognosis; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Risk Factors | 2019 |
Alterations of global histone H3K9 and H3K27 methylation levels in bladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Histones; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Methylation; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Tissue Array Analysis; Urinary Bladder Neoplasms; Urothelium | 2014 |
Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer.
Topics: Adult; Aged; Aged, 80 and over; Cell Nucleus; Colonic Neoplasms; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Male; Methylation; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Survival Analysis; Tissue Array Analysis | 2014 |
G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma.
Topics: Antigens, CD; Cadherins; Carcinoma, Squamous Cell; Cell Movement; Epithelial-Mesenchymal Transition; Flow Cytometry; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Histones; Humans; Lymphatic Metastasis; Methylation; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neoplastic Stem Cells; Prognosis; Squamous Cell Carcinoma of Head and Neck; Stem Cells; Transforming Growth Factor beta; Treatment Outcome; Wound Healing | 2015 |
Paired box 5 methylation detection by droplet digital PCR for ultra-sensitive deep surgical margins analysis of head and neck squamous cell carcinoma.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Disease-Free Survival; DNA; False Negative Reactions; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Methylation; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; PAX5 Transcription Factor; Polymerase Chain Reaction; Postoperative Period; Promoter Regions, Genetic; Prospective Studies | 2015 |
Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Glycoproteins; Hepatectomy; Humans; Liver Neoplasms; Male; Methylation; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Risk; Survival Rate; Young Adult | 2016 |
Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy.
Topics: Aged; Biomarkers, Tumor; Cadherins; Humans; Male; Methylation; Neoplasm Recurrence, Local; Prostatectomy; Prostatic Neoplasms | 2015 |
Integration of multiple "OMIC" biomarkers: A precision medicine strategy for lung cancer.
Topics: Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Cytokines; Early Detection of Cancer; Gene Expression; Humans; Lung Neoplasms; Mass Screening; Metabolomics; Methylation; MicroRNAs; Neoplasm Recurrence, Local; Neoplasm Staging; Precision Medicine; Smoking; Survival Rate; Tomography, X-Ray Computed | 2017 |
Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer.
Topics: Biomarkers, Tumor; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Disease Progression; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Histones; Humans; Kaplan-Meier Estimate; Methylation; MicroRNAs; Mutation; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Time Factors; Transcription, Genetic; Urinary Bladder Neoplasms | 2017 |
Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Glioblastoma; Humans; Methylation; Neoplasm Recurrence, Local; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Organophosphorus Compounds; Promoter Regions, Genetic; Randomized Controlled Trials as Topic | 2009 |
A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine.
Topics: Adenomatous Polyposis Coli Protein; Adult; Aged; Aged, 80 and over; Biological Assay; Humans; Methylation; Middle Aged; Neoplasm Recurrence, Local; Receptor, Endothelin B; Sensitivity and Specificity; Telomerase; Urinary Bladder Neoplasms; Urine | 2012 |
Analysis of the coding genome of diffuse large B-cell lymphoma.
Topics: Chromatin; Diploidy; DNA Mutational Analysis; Gene Dosage; Gene Expression Regulation, Leukemic; Genome, Human; Germinal Center; Humans; Lymphoma, Large B-Cell, Diffuse; Methylation; Neoplasm Recurrence, Local; Point Mutation; Polymorphism, Single Nucleotide; T-Lymphocytes | 2011 |
Global histone H3K27 methylation levels are different in localized and metastatic prostate cancer.
Topics: Histones; Humans; Male; Methylation; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prostatic Neoplasms | 2012 |
Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients.
Topics: Acetylation; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Histones; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Methylation; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Tissue Array Analysis | 2012 |
Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.
Topics: Adaptor Proteins, Signal Transducing; Aged; Aged, 80 and over; beta Catenin; Disease-Free Survival; Endometrial Neoplasms; Exons; Female; Humans; Kaplan-Meier Estimate; Methylation; Microsatellite Instability; Middle Aged; Multivariate Analysis; Mutation; MutL Protein Homolog 1; Neoplasm Recurrence, Local; Nuclear Proteins; Promoter Regions, Genetic; Proportional Hazards Models; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins p21(ras); PTEN Phosphohydrolase; ras Proteins; Risk Assessment; Sequence Analysis, DNA; Transcription Factors; Tumor Suppressor Protein p53; Wnt Signaling Pathway | 2012 |
Cancer: a changing global view.
Topics: Acetylation; Gene Expression Regulation, Neoplastic; Histones; Humans; Male; Methylation; Neoplasm Recurrence, Local; Prognosis; Prostatic Neoplasms; Protein Processing, Post-Translational | 2005 |
Global histone modification patterns predict risk of prostate cancer recurrence.
Topics: Acetylation; Gene Expression Regulation, Neoplastic; Histones; Humans; Immunohistochemistry; Male; Methylation; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; Protein Processing, Post-Translational; Recurrence | 2005 |
[An early detection of recurrence using reverse transcriptase-polymerase chain reaction (RT-PCR) and methylation-specific polymerase chain reaction (MSP) from peripheral blood in patients after gastrectomy].
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; DNA; Female; Gastrectomy; Humans; Male; Methylation; Middle Aged; Neoplasm Recurrence, Local; Polymerase Chain Reaction; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Stomach Neoplasms | 2006 |
Aberrant hypermethylation of p14ARF and O6-methylguanine-DNA methyltransferase genes in astrocytoma progression.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; CpG Islands; Female; Humans; Male; Methylation; Middle Aged; Mutation; Neoplasm Recurrence, Local; O(6)-Methylguanine-DNA Methyltransferase; Promoter Regions, Genetic; Survival Analysis; Tumor Suppressor Protein p14ARF; Tumor Suppressor Protein p53 | 2007 |
Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence.
Topics: Exons; Gene Deletion; Gene Frequency; Genes, p16; Homozygote; Humans; Methylation; Mutation; Neoplasm Recurrence, Local; Phenotype; Prognosis; Promoter Regions, Genetic; Proteins; Survival Analysis; Tumor Suppressor Protein p14ARF; Urinary Bladder Neoplasms | 1999 |